Managing intestinal failure–associated liver disease (IFALD) requires a two-pronged approach by specialty pharmacists: keeping an eye on the orphan drug pipeline for IFALD, and tracking potential causes of the disorder, including total parental nutrition (TPN), according to several experts.
The relationship between TPN and IFALD warrants the attention of clinicians who manage vulnerable patients, stressed Kathleen Gura, PharmD, the board director at the American Society